Skip to main content

05.04.2024 | Original Research: Qualitative Research

It’s Like A Partnership”: Exploring the Primary Care Experiences and Patient-Defined Goals of People Who Use Drugs

verfasst von: Katherine Dunham, MPH, Catherine Rivas, MPH, Paula Medina Blanco, BS, Betty Kolod, MD, MPH, Carli Salvati, LMSW, Katie Clark, PhD, Kimberly L. Sue, MD, PhD, Ashley Hagaman, PhD, MPH, Jeffrey J. Weiss, PhD, MS

Erschienen in: Journal of General Internal Medicine

Einloggen, um Zugang zu erhalten

Abstract

Background

Primary care is an important yet underutilized resource in addressing the overdose crisis. Previous studies have identified important aspects of primary care for people who use drugs (PWUD) and have found patient involvement in healthcare decisions and goal-setting to be especially critical. However, there has been limited research describing the primary care goals of PWUD. In harm reduction settings, where it is imperative that PWUD set their own goals, this research gap becomes especially relevant.

Objective

To explore how PWUD navigate primary care with a focus on understanding their primary care goals.

Design

A qualitative study using semi-structured interviews.

Participants

PWUD currently engaged in primary care at the Respectful and Equitable Access to Comprehensive Healthcare (REACH) Program, a harm reduction–based primary care program in New York City.

Approach

Between June 2022 and August 2022, we conducted 17 semi-structured interviews. Informed by phenomenology, transcripts were coded using both inductive and deductive codes and themes were developed using thematic analysis approaches.

Key Results

Phenomenological analysis identified four core components that, together, created an experience that participants described as “a partnership” between patient and provider: (1) patient-provider collaboration around patient-defined healthcare goals; (2) support provided by harm reduction–based approaches to primary care anchored in incrementalism and flexibility; (3) care teams’ ability to address healthcare system fragmentation; and (4) the creation of social connections through primary care. This holistic partnership fostered positive primary care experiences and supported participants’ self-defined care goals, thereby facilitating meaningful care outcomes.

Conclusions

To best meet the primary care goals of PWUD, these findings underscore the importance of primary care providers and programs facilitating such partnerships through organizational-level support anchored in harm reduction. Future research should explore how these experiences in primary care affect patient health outcomes, ultimately shaping best practices in the provision of high-quality primary care for PWUD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2022 National Survey on Drug Use and Health [Internet]. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2023 [cited 2023 Nov 22]. Available from: https://www.samhsa.gov/data/report/2022-nsduh-annual-national-report. Accessed 22 Nov 2023 Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2022 National Survey on Drug Use and Health [Internet]. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2023 [cited 2023 Nov 22]. Available from: https://​www.​samhsa.​gov/​data/​report/​2022-nsduh-annual-national-report. Accessed 22 Nov 2023
3.
Zurück zum Zitat Barry CL, Epstein AJ, Fiellin DA, Fraenkel L, Busch SH. Estimating demand for primary care-based treatment for substance and alcohol use disorders. Addict Abingdon Engl 2016;111(8):1376–84.CrossRef Barry CL, Epstein AJ, Fiellin DA, Fraenkel L, Busch SH. Estimating demand for primary care-based treatment for substance and alcohol use disorders. Addict Abingdon Engl 2016;111(8):1376–84.CrossRef
4.
Zurück zum Zitat Moallef S, Dale L, Homayra F, et al. Suboptimal nonmedical qualities of primary care linked with care avoidance among people who use drugs in a Canadian setting amid an integrated health care reform. J Subst Abuse Treat 2022;139:108784.PubMedPubMedCentralCrossRef Moallef S, Dale L, Homayra F, et al. Suboptimal nonmedical qualities of primary care linked with care avoidance among people who use drugs in a Canadian setting amid an integrated health care reform. J Subst Abuse Treat 2022;139:108784.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Kendall CE, Boucher LM, Donelle J, et al. Engagement in primary health care among marginalized people who use drugs in Ottawa, Canada. BMC Health Serv Res 2020;20:837.PubMedCrossRef Kendall CE, Boucher LM, Donelle J, et al. Engagement in primary health care among marginalized people who use drugs in Ottawa, Canada. BMC Health Serv Res 2020;20:837.PubMedCrossRef
6.
Zurück zum Zitat Meyerson BE, Russell DM, Kichler M, Atkin T, Fox G, Coles HB. I don’t even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 2019. Int J Drug Policy 2021;93:103112.PubMedCrossRef Meyerson BE, Russell DM, Kichler M, Atkin T, Fox G, Coles HB. I don’t even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 2019. Int J Drug Policy 2021;93:103112.PubMedCrossRef
7.
Zurück zum Zitat Dion K, Chiodo L, Whynott L, et al. Exploration of the unmet health care needs of people who inject drugs. J Am Assoc Nurse Pract 2020;32(1):60–9.PubMedCrossRef Dion K, Chiodo L, Whynott L, et al. Exploration of the unmet health care needs of people who inject drugs. J Am Assoc Nurse Pract 2020;32(1):60–9.PubMedCrossRef
8.
Zurück zum Zitat Jackson LA, McWilliam S, Martin F, et al. Key challenges in providing services to people who use drugs: The perspectives of people working in emergency departments and shelters in Atlantic Canada. Drugs Educ Prev Policy 2014;21(3):244–53.CrossRef Jackson LA, McWilliam S, Martin F, et al. Key challenges in providing services to people who use drugs: The perspectives of people working in emergency departments and shelters in Atlantic Canada. Drugs Educ Prev Policy 2014;21(3):244–53.CrossRef
9.
Zurück zum Zitat Motavalli D, Taylor JL, Childs E, et al. “Health Is on the Back Burner:” Multilevel Barriers and Facilitators to Primary Care Among People Who Inject Drugs. J Gen Intern Med 2021;36(1):129–37.PubMedCrossRef Motavalli D, Taylor JL, Childs E, et al. “Health Is on the Back Burner:” Multilevel Barriers and Facilitators to Primary Care Among People Who Inject Drugs. J Gen Intern Med 2021;36(1):129–37.PubMedCrossRef
11.
Zurück zum Zitat Ross LE, Vigod S, Wishart J, et al. Barriers and facilitators to primary care for people with mental health and/or substance use issues: a qualitative study. BMC Fam Pract 2015;16(1):135.PubMedPubMedCentralCrossRef Ross LE, Vigod S, Wishart J, et al. Barriers and facilitators to primary care for people with mental health and/or substance use issues: a qualitative study. BMC Fam Pract 2015;16(1):135.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat National Academies of Sciences, Engineering, and Medicine. Medications for Opioid Use Disorder Save Lives [Internet]. Washington, D.C.: National Academies Press; 2019 [cited 2022 Feb 22]. Available from: https://doi.org/10.17226/25310 National Academies of Sciences, Engineering, and Medicine. Medications for Opioid Use Disorder Save Lives [Internet]. Washington, D.C.: National Academies Press; 2019 [cited 2022 Feb 22]. Available from: https://​doi.​org/​10.​17226/​25310
13.
Zurück zum Zitat Barry MJ, Edgman-Levitan S. Shared Decision Making — The Pinnacle of Patient-Centered Care. N Engl J Med 2012;366(9):780–1.PubMedCrossRef Barry MJ, Edgman-Levitan S. Shared Decision Making — The Pinnacle of Patient-Centered Care. N Engl J Med 2012;366(9):780–1.PubMedCrossRef
15.
Zurück zum Zitat Melin J, Nordin Å, Feldthusen C, Danielsson L. Goal-setting in physiotherapy: exploring a person-centered perspective. Physiother Theory Pract 2021;37(8):863–80.PubMedCrossRef Melin J, Nordin Å, Feldthusen C, Danielsson L. Goal-setting in physiotherapy: exploring a person-centered perspective. Physiother Theory Pract 2021;37(8):863–80.PubMedCrossRef
16.
Zurück zum Zitat Kuipers SJ, Nieboer AP, Cramm JM. Making care more patient centered; experiences of healthcare professionals and patients with multimorbidity in the primary care setting. BMC Fam Pract 2021;22:70.PubMedPubMedCentralCrossRef Kuipers SJ, Nieboer AP, Cramm JM. Making care more patient centered; experiences of healthcare professionals and patients with multimorbidity in the primary care setting. BMC Fam Pract 2021;22:70.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Kelley AT, Incze MA, Baylis JD, et al. Patient-centered quality measurement for opioid use disorder: Development of a taxonomy to address gaps in research and practice. Subst Abuse 2022;43(1):1286–99.CrossRef Kelley AT, Incze MA, Baylis JD, et al. Patient-centered quality measurement for opioid use disorder: Development of a taxonomy to address gaps in research and practice. Subst Abuse 2022;43(1):1286–99.CrossRef
19.
Zurück zum Zitat Park SE, Grogan CM, Mosley JE, Humphreys K, Pollack HA, Friedmann PD. Correlates of Patient-Centered Care Practices at U.S. Substance Use Disorder Clinics. Psychiatr Serv Wash DC 2020;71(1):35–42.CrossRef Park SE, Grogan CM, Mosley JE, Humphreys K, Pollack HA, Friedmann PD. Correlates of Patient-Centered Care Practices at U.S. Substance Use Disorder Clinics. Psychiatr Serv Wash DC 2020;71(1):35–42.CrossRef
20.
Zurück zum Zitat Press KR, Zornberg GZ, Geller G, Carrese J, Fingerhood MI. What patients with addiction disorders need from their primary care physicians: A qualitative study. Subst Abuse 2016;37(2):349–55.CrossRef Press KR, Zornberg GZ, Geller G, Carrese J, Fingerhood MI. What patients with addiction disorders need from their primary care physicians: A qualitative study. Subst Abuse 2016;37(2):349–55.CrossRef
21.
Zurück zum Zitat Alves PCG, Stevenson FA, Mylan S, Pires N, Winstock A, Ford C. How do people who use drugs experience treatment? A qualitative analysis of views about opioid substitution treatment in primary care (iCARE study). BMJ Open 2021;11(2):e042865.PubMedPubMedCentralCrossRef Alves PCG, Stevenson FA, Mylan S, Pires N, Winstock A, Ford C. How do people who use drugs experience treatment? A qualitative analysis of views about opioid substitution treatment in primary care (iCARE study). BMJ Open 2021;11(2):e042865.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Alves P, Sales C, Ashworth M. Does outcome measurement of treatment for substance use disorder reflect the personal concerns of patients? A scoping review of measures recommended in Europe. Drug Alcohol Depend 2017;179:299–308.PubMedCrossRef Alves P, Sales C, Ashworth M. Does outcome measurement of treatment for substance use disorder reflect the personal concerns of patients? A scoping review of measures recommended in Europe. Drug Alcohol Depend 2017;179:299–308.PubMedCrossRef
23.
Zurück zum Zitat Chai D, Rosic T, Panesar B, et al. Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder. JAMA Netw Open 2021;4(8):e2119600.PubMedPubMedCentralCrossRef Chai D, Rosic T, Panesar B, et al. Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder. JAMA Netw Open 2021;4(8):e2119600.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Dennis BB, Sanger N, Bawor M, et al. A call for consensus in defining efficacy in clinical trials for opioid addiction: combined results from a systematic review and qualitative study in patients receiving pharmacological assisted therapy for opioid use disorder. Trials 2020;21:30.PubMedPubMedCentralCrossRef Dennis BB, Sanger N, Bawor M, et al. A call for consensus in defining efficacy in clinical trials for opioid addiction: combined results from a systematic review and qualitative study in patients receiving pharmacological assisted therapy for opioid use disorder. Trials 2020;21:30.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Neale J, Vitoratou S, Finch E, et al. DEVELOPMENT AND VALIDATION OF ‘SURE’: A PATIENT REPORTED OUTCOME MEASURE (PROM) FOR RECOVERY FROM DRUG AND ALCOHOL DEPENDENCE. Drug Alcohol Depend 2016;165:159–67.PubMedPubMedCentralCrossRef Neale J, Vitoratou S, Finch E, et al. DEVELOPMENT AND VALIDATION OF ‘SURE’: A PATIENT REPORTED OUTCOME MEASURE (PROM) FOR RECOVERY FROM DRUG AND ALCOHOL DEPENDENCE. Drug Alcohol Depend 2016;165:159–67.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Sanger N, Panesar B, Rosic T, et al. The future of precision medicine in opioid use disorder: inclusion of patient-important outcomes in clinical trials. Braz J Psychiatry 2020;43(2):138–46.PubMedCentralCrossRef Sanger N, Panesar B, Rosic T, et al. The future of precision medicine in opioid use disorder: inclusion of patient-important outcomes in clinical trials. Braz J Psychiatry 2020;43(2):138–46.PubMedCentralCrossRef
27.
28.
Zurück zum Zitat Dunham K, Giardina M, Kolod B, et al. Transitioning Clinical Care for People Who Use Drugs to Telemedicine: Lessons Learned One Year into the COVID-19 Pandemic. Telemed E-Health 2021;27(8):929–33.CrossRef Dunham K, Giardina M, Kolod B, et al. Transitioning Clinical Care for People Who Use Drugs to Telemedicine: Lessons Learned One Year into the COVID-19 Pandemic. Telemed E-Health 2021;27(8):929–33.CrossRef
29.
Zurück zum Zitat Riazi F, Toribio W, Irani E, et al. Community Case Study of Naloxone Distribution by Hospital-Based Harm Reduction Program for People Who Use Drugs in New York City. Front Sociol 2021;6:619683.PubMedPubMedCentralCrossRef Riazi F, Toribio W, Irani E, et al. Community Case Study of Naloxone Distribution by Hospital-Based Harm Reduction Program for People Who Use Drugs in New York City. Front Sociol 2021;6:619683.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Woodrell C, Weiss J, Branch A, et al. Primary Care-Based Hepatitis C Treatment Outcomes With First-Generation Direct-Acting Agents. J Addict Med 2015;9(5):405–10.PubMedPubMedCentralCrossRef Woodrell C, Weiss J, Branch A, et al. Primary Care-Based Hepatitis C Treatment Outcomes With First-Generation Direct-Acting Agents. J Addict Med 2015;9(5):405–10.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Vu TM, Toribio W, Riazi F, et al. Increasing Access to Hepatitis C Virus Medications: A Program Model Using Patient Navigators and Specialty Pharmacy to Obtain Prior Authorization Approval. J Manag Care Spec Pharm 2018;24(4):329–33.PubMed Vu TM, Toribio W, Riazi F, et al. Increasing Access to Hepatitis C Virus Medications: A Program Model Using Patient Navigators and Specialty Pharmacy to Obtain Prior Authorization Approval. J Manag Care Spec Pharm 2018;24(4):329–33.PubMed
32.
Zurück zum Zitat Gardenier D, Woody A, Amory C, Weiss JJ. Interprofessional team-based approach to patients with chronic hepatitis C and personality disorder: Three case studies. Arch Psychiatr Nurs 2019;33(4):352–7.PubMedCrossRef Gardenier D, Woody A, Amory C, Weiss JJ. Interprofessional team-based approach to patients with chronic hepatitis C and personality disorder: Three case studies. Arch Psychiatr Nurs 2019;33(4):352–7.PubMedCrossRef
33.
Zurück zum Zitat Wang L, Weiss J, Ryan EB, Waldman J, Rubin S, Griffin JL. Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic. J Subst Abuse Treat 2021;124:108272.PubMedPubMedCentralCrossRef Wang L, Weiss J, Ryan EB, Waldman J, Rubin S, Griffin JL. Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic. J Subst Abuse Treat 2021;124:108272.PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Ziff J, Vu T, Dvir D, et al. Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City. Harm Reduct J 2021;18(1):38.PubMedPubMedCentralCrossRef Ziff J, Vu T, Dvir D, et al. Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City. Harm Reduct J 2021;18(1):38.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Hughes TM, Kalicki A, Huxley-Reicher Z, et al. A Medical Student-Led Model for Telephone-Based Opioid Overdose Education and Naloxone Distribution during the Covid-19 Pandemic. Subst Abuse 2022;43(1):988–92.CrossRef Hughes TM, Kalicki A, Huxley-Reicher Z, et al. A Medical Student-Led Model for Telephone-Based Opioid Overdose Education and Naloxone Distribution during the Covid-19 Pandemic. Subst Abuse 2022;43(1):988–92.CrossRef
36.
Zurück zum Zitat Guba EG. Criteria for assessing the trustworthiness of naturalistic inquiries. ECTJ 1981;29(2):75–91.CrossRef Guba EG. Criteria for assessing the trustworthiness of naturalistic inquiries. ECTJ 1981;29(2):75–91.CrossRef
37.
Zurück zum Zitat Moser A, Korstjens I. Series: Practical guidance to qualitative research. Part 3: Sampling, data collection and analysis. Eur J Gen Pract 2017;24(1):9–18.PubMedPubMedCentralCrossRef Moser A, Korstjens I. Series: Practical guidance to qualitative research. Part 3: Sampling, data collection and analysis. Eur J Gen Pract 2017;24(1):9–18.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Rapp CA, Saleebey D, Sullivan WP. The Future of Strengths-Based Social Work. Adv Soc Work 2005;6(1):79–90.CrossRef Rapp CA, Saleebey D, Sullivan WP. The Future of Strengths-Based Social Work. Adv Soc Work 2005;6(1):79–90.CrossRef
40.
Zurück zum Zitat Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3(2):77–101.CrossRef Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3(2):77–101.CrossRef
42.
43.
Zurück zum Zitat Willig C. Reflections on the Use of a Phenomenological Method. Qual Res Psychol 2007;4(3):209–25.CrossRef Willig C. Reflections on the Use of a Phenomenological Method. Qual Res Psychol 2007;4(3):209–25.CrossRef
44.
Zurück zum Zitat Muncan B, Walters SM, Ezell J, Ompad DC. “They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J 2020;17:53.PubMedPubMedCentralCrossRef Muncan B, Walters SM, Ezell J, Ompad DC. “They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J 2020;17:53.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Chan Carusone S, Guta A, Robinson S, et al. “Maybe if I stop the drugs, then maybe they’d care?”—hospital care experiences of people who use drugs. Harm Reduct J 2019;16:16.PubMedPubMedCentralCrossRef Chan Carusone S, Guta A, Robinson S, et al. “Maybe if I stop the drugs, then maybe they’d care?”—hospital care experiences of people who use drugs. Harm Reduct J 2019;16:16.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Fong C, Mateu-Gelabert P, Ciervo C, et al. Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City. Drug Alcohol Depend 2021;221:108589.PubMedPubMedCentralCrossRef Fong C, Mateu-Gelabert P, Ciervo C, et al. Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City. Drug Alcohol Depend 2021;221:108589.PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat McNeil R, Small W, Lampkin H, Shannon K, Kerr T. “People Knew They Could Come Here to Get Help”: An Ethnographic Study of Assisted Injection Practices at a Peer-Run ‘Unsanctioned’ Supervised Drug Consumption Room in a Canadian Setting. AIDS Behav 2014;18(3):473–85.PubMedPubMedCentralCrossRef McNeil R, Small W, Lampkin H, Shannon K, Kerr T. “People Knew They Could Come Here to Get Help”: An Ethnographic Study of Assisted Injection Practices at a Peer-Run ‘Unsanctioned’ Supervised Drug Consumption Room in a Canadian Setting. AIDS Behav 2014;18(3):473–85.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Ford‐Gilboe M, Wathen CN, Varcoe C, et al. How Equity‐Oriented Health Care Affects Health: Key Mechanisms and Implications for Primary Health Care Practice and Policy. Milbank Q 2018;96(4):635–71.PubMedPubMedCentralCrossRef Ford‐Gilboe M, Wathen CN, Varcoe C, et al. How Equity‐Oriented Health Care Affects Health: Key Mechanisms and Implications for Primary Health Care Practice and Policy. Milbank Q 2018;96(4):635–71.PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Shields LBE, LaRocco M, Young MW, Flanders K. Using a Harm Reduction Approach to Treat Inpatients With Substance Use Disorders. JONA J Nurs Adm 2023;53(3):138.CrossRef Shields LBE, LaRocco M, Young MW, Flanders K. Using a Harm Reduction Approach to Treat Inpatients With Substance Use Disorders. JONA J Nurs Adm 2023;53(3):138.CrossRef
50.
Zurück zum Zitat Snow RL, Simon RE, Jack HE, Oller D, Kehoe L, Wakeman SE. Patient experiences with a transitional, low-threshold clinic for the treatment of substance use disorder: A qualitative study of a bridge clinic. J Subst Abuse Treat 2019;107:1–7.PubMedCrossRef Snow RL, Simon RE, Jack HE, Oller D, Kehoe L, Wakeman SE. Patient experiences with a transitional, low-threshold clinic for the treatment of substance use disorder: A qualitative study of a bridge clinic. J Subst Abuse Treat 2019;107:1–7.PubMedCrossRef
51.
Zurück zum Zitat Khan GK, Harvey L, Johnson S, et al. Integration of a community-based harm reduction program into a safety net hospital: a qualitative study. Harm Reduct J 2022;19:35.PubMedPubMedCentralCrossRef Khan GK, Harvey L, Johnson S, et al. Integration of a community-based harm reduction program into a safety net hospital: a qualitative study. Harm Reduct J 2022;19:35.PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Kapadia SN, Griffin JL, Waldman J, Ziebarth NR, Schackman BR, Behrends CN. A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative Study. J Gen Intern Med 2021;36(7):1898–905.PubMedPubMedCentralCrossRef Kapadia SN, Griffin JL, Waldman J, Ziebarth NR, Schackman BR, Behrends CN. A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative Study. J Gen Intern Med 2021;36(7):1898–905.PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Englander H, Davis CS. Hospital Standards of Care for People with Substance Use Disorder. N Engl J Med 2022;387(8):672–5.PubMedCrossRef Englander H, Davis CS. Hospital Standards of Care for People with Substance Use Disorder. N Engl J Med 2022;387(8):672–5.PubMedCrossRef
54.
Zurück zum Zitat Olsen Y, Sharfstein JM. Confronting the Stigma of Opioid Use Disorder—and Its Treatment. JAMA 2014;311(14):1393–4.PubMedCrossRef Olsen Y, Sharfstein JM. Confronting the Stigma of Opioid Use Disorder—and Its Treatment. JAMA 2014;311(14):1393–4.PubMedCrossRef
55.
Zurück zum Zitat Brown SA. Stigma towards Marijuana Users and Heroin Users. J Psychoactive Drugs 2015;47(3):213–20.PubMedCrossRef Brown SA. Stigma towards Marijuana Users and Heroin Users. J Psychoactive Drugs 2015;47(3):213–20.PubMedCrossRef
56.
Zurück zum Zitat Barry CL, McGinty EE, Pescosolido BA, Goldman HH. Stigma, Discrimination, Treatment Effectiveness, and Policy: Public Views About Drug Addiction and Mental Illness. Psychiatr Serv 2014;65(10):1269–72.PubMedPubMedCentralCrossRef Barry CL, McGinty EE, Pescosolido BA, Goldman HH. Stigma, Discrimination, Treatment Effectiveness, and Policy: Public Views About Drug Addiction and Mental Illness. Psychiatr Serv 2014;65(10):1269–72.PubMedPubMedCentralCrossRef
58.
Zurück zum Zitat Ingram I, Kelly P, Deane F, Baker A, Dingle G. Perceptions of loneliness among people accessing treatment for substance use disorders. DRUG ALCOHOL Rev 2020;39(5):484–94.PubMedCrossRef Ingram I, Kelly P, Deane F, Baker A, Dingle G. Perceptions of loneliness among people accessing treatment for substance use disorders. DRUG ALCOHOL Rev 2020;39(5):484–94.PubMedCrossRef
60.
Zurück zum Zitat McDonagh J, Williams C, Oldfield B, Cruz-Jose D, Olson D. The Association of Loneliness and Non-prescribed Opioid Use in Patients With Opioid Use Disorder. J Addict Med 2020;14(6):489–93.PubMedCrossRef McDonagh J, Williams C, Oldfield B, Cruz-Jose D, Olson D. The Association of Loneliness and Non-prescribed Opioid Use in Patients With Opioid Use Disorder. J Addict Med 2020;14(6):489–93.PubMedCrossRef
61.
Zurück zum Zitat Farmer A, Wang Y, Peterson N, Borys S, Hallcom D. Social Isolation Profiles and Older Adult Substance Use: A Latent Profile Analysis. J Gerontol Ser B-Psychol Sci Soc Sci 2022;77(5):919–29. Farmer A, Wang Y, Peterson N, Borys S, Hallcom D. Social Isolation Profiles and Older Adult Substance Use: A Latent Profile Analysis. J Gerontol Ser B-Psychol Sci Soc Sci 2022;77(5):919–29.
62.
Zurück zum Zitat Lennox R, Lamarche L, O’Shea T. Peer support workers as a bridge: a qualitative study exploring the role of peer support workers in the care of people who use drugs during and after hospitalization. Harm Reduct J 2021;18(1):19.PubMedPubMedCentralCrossRef Lennox R, Lamarche L, O’Shea T. Peer support workers as a bridge: a qualitative study exploring the role of peer support workers in the care of people who use drugs during and after hospitalization. Harm Reduct J 2021;18(1):19.PubMedPubMedCentralCrossRef
63.
Zurück zum Zitat Snyder H, Kalmin MM, Moulin A, et al. Rapid Adoption of Low-Threshold Buprenorphine Treatment at California Emergency Departments Participating in the CA Bridge Program. Ann Emerg Med 2021;78(6):759–72.PubMedCrossRef Snyder H, Kalmin MM, Moulin A, et al. Rapid Adoption of Low-Threshold Buprenorphine Treatment at California Emergency Departments Participating in the CA Bridge Program. Ann Emerg Med 2021;78(6):759–72.PubMedCrossRef
64.
Zurück zum Zitat Courtin E, Knapp M. Social isolation, loneliness and health in old age: a scoping review. Health Soc Care Community 2017;25(3):799–812.PubMedCrossRef Courtin E, Knapp M. Social isolation, loneliness and health in old age: a scoping review. Health Soc Care Community 2017;25(3):799–812.PubMedCrossRef
65.
Zurück zum Zitat Han BH, Cotton BP, Polydorou S, et al. Geriatric Conditions Among Middle-aged and Older Adults on Methadone Maintenance Treatment: A Pilot Study. J Addict Med 2022;16(1):110–3.PubMedPubMedCentralCrossRef Han BH, Cotton BP, Polydorou S, et al. Geriatric Conditions Among Middle-aged and Older Adults on Methadone Maintenance Treatment: A Pilot Study. J Addict Med 2022;16(1):110–3.PubMedPubMedCentralCrossRef
66.
Zurück zum Zitat Chayama KL, Ng C, Small W, Ivsins A, McNeil R. “It’s a burden, it’s a nuisance. I wish I didn’t have these other ailments”: a qualitative exploration of comorbidities management among older people living with HIV who use drugs in Vancouver, British Columbia. J Int AIDS Soc 2021;24(10):e25785.PubMedPubMedCentralCrossRef Chayama KL, Ng C, Small W, Ivsins A, McNeil R. “It’s a burden, it’s a nuisance. I wish I didn’t have these other ailments”: a qualitative exploration of comorbidities management among older people living with HIV who use drugs in Vancouver, British Columbia. J Int AIDS Soc 2021;24(10):e25785.PubMedPubMedCentralCrossRef
67.
Zurück zum Zitat Collins AB, Bardwell G, McNeil R, Boyd J. Gender and the overdose crisis in North America: Moving past gender-neutral approaches in the public health response. Int J Drug Policy 2019;69:43–5.PubMedPubMedCentralCrossRef Collins AB, Bardwell G, McNeil R, Boyd J. Gender and the overdose crisis in North America: Moving past gender-neutral approaches in the public health response. Int J Drug Policy 2019;69:43–5.PubMedPubMedCentralCrossRef
68.
Zurück zum Zitat Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry 2021;34(4):344–50.PubMedPubMedCentralCrossRef Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry 2021;34(4):344–50.PubMedPubMedCentralCrossRef
Metadaten
Titel
“It’s Like A Partnership”: Exploring the Primary Care Experiences and Patient-Defined Goals of People Who Use Drugs
verfasst von
Katherine Dunham, MPH
Catherine Rivas, MPH
Paula Medina Blanco, BS
Betty Kolod, MD, MPH
Carli Salvati, LMSW
Katie Clark, PhD
Kimberly L. Sue, MD, PhD
Ashley Hagaman, PhD, MPH
Jeffrey J. Weiss, PhD, MS
Publikationsdatum
05.04.2024
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-024-08743-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.